Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

SOD mimetic M-40403 may allow high-dose IL-2 immunotherapy in advanced cancers

March 27, 2001

Preclinical data presented for TLK-199 at AACR meeting

March 27, 2001

SafeScience's anticancer drug GBC-590 shows activity in phase II trial

March 27, 2001

AVI BioPharma's antisense agent slows tumor growth in mice

March 26, 2001

MGI Pharma commences new phase II trial of irofulven for treatment of ovarian cancer

March 26, 2001

Lynx Therapeutics and UroGene collaborate to identify anticancer genes

March 26, 2001

Hungarian scientists claim new series of heterocyclic angiogenesis inhibitors

March 23, 2001

Aventis antitumor agents act by inhibiting Ras farnesylation

March 23, 2001

Two patents issued to Novuspharma cover new antitumor agents

March 23, 2001

MediGene's NV-1020 shows good safety profile in phase I

March 23, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...